Clinical Study
Clinical and Genetic Study of Algerian Patients with Spinal Muscular Atrophy
Table 7
Frequency of SMN1 homozygous deletion in SMA around the world.
| References | Countries | patients | SMN Del (%) |
| [38] | Korea 2001 | 37 | 32,43% | [39] | Vietnam 2003 | 17 | 41,17% | [40] | Johannesburg 2007 | 92 | 51% | [41] | Egypt 2001 | 33 | 55% | [42] | Russia 2001 | 57 | 65% | [33] | Brasilia 1999 | 87 | 69% | Our study | Algeria 2009 | 92 | 75% | [43] | India 2005 | 45 | 76% | [44] | Saudi Arabia 1997 | 16 | 82% | [55] | Morocco 2003 | 54 | 83,33% | [56] | Turkey 2000 | 60 | 85% | [57] | Germany 1995 | 195 | 90% | [58] | Spain 1995 | 54 | 91% | [59] | Holland 1995 | 103 | 93% | [60] | Japan 2002 | 32 | 94% | [61] | Tunis 2006 | 60 | 95% | [62] | Iran 2004 | 22 | 95,40% | [24] | UK 1995 | 140 | 97,80% | [63] | Kuwait 2001 | 46 | 97,82% | [8] | France 1995 | 229 | 98% | [64] | Taiwan 1995 | 42 | 100% |
|
|